Ironwood Pharmaceuticals (IRWD) Notes Payables (2014 - 2019)

Ironwood Pharmaceuticals has disclosed Notes Payables across 5 years of filings, most recently posting $48.8 million for Q2 2019.

• In Q2 2019, Notes Payables rose 96.28% year-over-year to $48.8 million; the TTM figure through Jun 2019 stood at $48.8 million (up 96.28% YoY), while the FY2018 annual figure was $47.6 million, changed N/A from the prior year.
• Notes Payables came in at $48.8 million for Q2 2019 at Ironwood Pharmaceuticals, up from $46.0 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $48.8 million in Q2 2019 to a low of $8.4 million in Q3 2016.
• Average Notes Payables over 4 years is $28.2 million, with a median of $25.0 million recorded in 2015.
• Year-over-year, Notes Payables sank 58.23% in 2016 and soared 284.35% in 2019.
• Over 4 years, Notes Payables stood at $25.0 million in 2015, then tumbled by 66.33% to $8.4 million in 2016, then soared by 465.78% to $47.6 million in 2018, then grew by 2.61% to $48.8 million in 2019.
• Per Business Quant data, the three most recent Notes Payables figures were $48.8 million in Q2 2019, $46.0 million in Q1 2019, and $47.6 million in Q4 2018.